Committee recommends seladelpar approval in EU for treating PBC
A branch of the European Medicines Agency (EMA) has recommended that Gilead Sciences’…
Cholangitis is a liver condition characterized by inflammation in the bile ducts, most commonly caused by a bacterial infection but also may develop due to a variety of other causes.
Read moreA variety of treatments may be used to treat cholangitis, depending on the type and whether it is acute or chronic.
Read moreA branch of the European Medicines Agency (EMA) has recommended that Gilead Sciences’…
Sleep disorders affect about half of adults with primary biliary cholangitis (PBC), and…